BioNTech SE Sponsored ADR
(NASDAQ: BNTX)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

88.080 -

-1.470 (-1.64%)
Jarak 87.805 - 89.260   (1.66%)
Buka 89.260
Tutup Terdahulu 89.550
Harga Beli 88.000
Beli Purata 100
Jual Beli 88.210
Purata Jual 300
Purata 449,965
Nilai 27,894,302
Catatan -
Harga tertunda. Dikemas kini pada 19 May 2026 01:15.
Data dikuasakan oleh
Lihat Semua Acara

Loading Chart...

Please login to view stock data and analysis